Results 251 to 260 of about 82,070 (285)

The Impact of Moderate to High Intensity Physical Activity on Sleep Health in Cancer Survivors

open access: yesCancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Background Sleep disturbances are common among cancer survivors and negatively impact quality of life. Regular moderate‐ to high‐intensity physical activity may provide a cost‐effective, low‐risk alternative strategy to improve sleep. Methods Data collected as part of two distinct studies, the Detroit Research On Cancer Survivors (ROCS) cohort
Grace E. Markey   +10 more
wiley   +1 more source

Identifying Gaps and Opportunities to Improve Ototoxicity Management in Veterans With Cancer: Evidence From a Retrospective Cohort and Oncology Provider Survey

open access: yesCancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Purpose Identify factors influencing audiological care for chemotherapy‐induced ototoxicity from the perspectives of oncology providers in the Veterans Health Administration (VA), and quantify audiology service use among Veterans receiving ototoxic chemotherapies.
Cecilia Lacey   +9 more
wiley   +1 more source

First reported case of pediatric radiation treatment with magnetic resonance image guided radiation therapy [PDF]

open access: yes, 2019
Green, Olga L   +6 more
core   +1 more source

Patient reported outcomes following MR-guided radiotherapy for prostate cancer: a systematic review and meta-analysis.

open access: yesInternational Journal of Radiation Oncology, Biology, Physics
J. Westerhoff   +12 more
semanticscholar   +1 more source

Identification of Glioma Phenotypic Subtypes From Multimodal MRI Data Using Hierarchical Multi‐Kernel Learning

open access: yesCancer Medicine, Volume 15, Issue 2, February 2026.
Our study identified glioma phenotypic subtypes based on T1CE and T2FLAIR radiomic features, along with associated pathway activities, providing real‐time insights into tumor dynamics to guide preoperative clinical decision‐making and improve patient management.
Junyu Yan   +9 more
wiley   +1 more source

Global, Regional, and National Burden of Tracheal, Bronchial, and Lung Cancer Attributable to Low Fruit Intake From 1990 to 2021

open access: yesCancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Background Low fruit intake has been identified as a significant modifiable risk factor for tracheal, bronchial, and lung (TBL) cancer. This study aims to quantify the global, regional, and national burden of TBL cancer attributable to low fruit intake from 1990 to 2021.
Jing‐li Li   +4 more
wiley   +1 more source

Fractionated Gamma Knife Radiation for Papillary Tumor of the Pineal Region: A Case Report and Literature Review

open access: yesClinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Papillary tumor of the pineal region (PTPR) is a rare central nervous system neoplasm with an unpredictable clinical course. Gross total resection, the preferred treatment, is often unachievable due to the tumor's deep‐seated location, necessitating alternative therapies.
Arad Iranmehr   +6 more
wiley   +1 more source

Retrospective analysis of cutaneous immune‐related adverse events following checkpoint inhibitor therapy in melanoma patients reveals increased risk associated with the HLA‐B*51:01 allele

open access: yesCancer, Volume 132, Issue 3, 1 February 2026.
ABSTRACT Background While immune checkpoint inhibitors (ICIs) have shown significant efficacy, a common side effect is cutaneous immune‐related adverse events (irAEs). This study focuses on exploring the association between specific human leukocyte antigen (HLA) alleles and the development of cutaneous irAEs in melanoma patients undergoing ICI ...
Mckenzie DiLeo   +12 more
wiley   +1 more source

A Giant Thoracic ALK‐Rearranged Mesenchymal Neoplasm in a Child

open access: yesCancer Reports, Volume 9, Issue 2, February 2026.
ABSTRACT Background Mesenchymal neoplasms characterized by ALK fusions mainly include inflammatory myofibroblastic tumors (IMTs) and epithelioid fibrous histiocytomas (EFHs). More recently, ALK‐rearranged mesenchymal tumors that are not IMTs or EFHs, characterized by S100 and CD34 coexpression, have been reported in a few small series and isolated case
Sheng Gao   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy